OpGen
OPGN
$0.51
Share price
-3.21%
Change (1 day)
-37.96%
Change (1 year)
Categories
OpGen (OPGN) - Cash on Hand
Cash on Hand as of September 2023 : $0.29 M
According to OpGen
's latest financial reports the company has $0.29 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
OpGen - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $7.44 M | -79.38% |
| 2021-12-31 | $36.08 M | 170.05% |
| 2020-12-31 | $13.36 M | 393.33% |
| 2019-12-31 | $2.7 M | -40.77% |
| 2018-12-31 | $4.57 M | 147.54% |
| 2017-12-31 | $1.84 M | -55.14% |
| 2016-12-31 | $4.11 M | -47.31% |
| 2015-12-31 | $7.81 M | 942.57% |
| 2014-12-31 | $0.74 M | -46.48% |
| 2013-12-31 | $1.4 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.21 B | 74,539.66% | 🇺🇸 USA |
 Enzo Biochem ENZ | $60.24 M | 20,485.22% | 🇺🇸 USA |